Viewing nowOlmesartan Medoxomil 40mg Tablet
Olmesartan Medoxomil 40mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

MFDS item code 200600115 · Notified 2006.04.25 · Insurance code 641602010
Treatment of essential hypertension
Essential hypertension is a condition of increased blood pressure without a specific cause, requiring appropriate treatment for heart and vascular health. This medication helps to stably lower blood pressure, reducing the burden on blood vessels and aiding in the prevention of complications such as heart disease and stroke. Regular use maintains blood pressure control and improves overall cardiovascular health. Additionally, lifestyle modifications are also recommended alongside drug therapy. This medication is used for the treatment of essential hypertension.
<Adults> The recommended initial dose is 10mg once daily, taken with or without food. If blood pressure is not adequately controlled at this dose, increase to 20mg once daily. If additional blood pressure reduction is needed, the dose may be increased to a maximum of 40mg daily. The blood pressure-lowering effect appears within 2 weeks after starting treatment and reaches its maximum effect at approximately 8 weeks. If blood pressure is not controlled with this medicine alone, it may be administered in combination with a thiazide diuretic such as hydrochlorothiazide. To improve adherence, it is recommended that the medicine be taken at the same time each day (e.g., in the morning), if possible. For patients who may have reduced effective intravascular volume (e.g., patients receiving diuretics, particularly those with renal impairment), it is recommended to start treatment at a low dose while closely monitoring their condition. <Older adults> No dosage adjustment is necessary when administering this medicine to patients aged 65 years or older. Although no overall differences in efficacy or safety have been observed between older and younger patients, the possibility of a more sensitive response in some older patients cannot be ruled out. <Patients with renal impairment> The maximum dose for patients with mild to moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. <Patients with hepatic impairment> No dosage adjustment is necessary for patients with mild hepatic impairment. For patients with moderate hepatic impairment, the recommended initial dose is 10mg once daily, which may be increased to a maximum of 20mg daily. Use in patients with severe hepatic impairment is not recommended because there is no experience with its use in these patients.
<Pediatric patients> Safety and efficacy in pediatric patients have not been established.
This medication can cause serious harm or death to the fetus and newborn if taken during the second and third trimester of pregnancy, so it must be discontinued immediately upon confirmation of pregnancy. Patients who are allergic to any component of this medication, are pregnant or breastfeeding, are undergoing kidney dialysis, or have severe liver disease or biliary obstruction should not take this medication. Patients with specific genetic issues such as lactose intolerance should also avoid this medication. Patients with decreased blood volume or sodium may experience hypotension, so it is important to check their condition carefully before use and monitor hypotension symptoms during use. Patients with severe heart failure or impaired renal function may have worsening kidney function when taking this medication, thus regular blood tests and monitoring are necessary. Caution is also needed for patients with renal vessel problems, those at risk for hyperkalemia, and those with certain heart conditions. Dizziness may occur during treatment, so driving or operating hazardous machinery should be avoided. While this medication is generally safe for the treatment of hypertension in most patients, some may experience side effects such as dizziness, headache, abdominal pain, and muscle pain. Rarely, serious side effects such as angioedema, liver function abnormalities, hyperkalemia, and acute renal failure can occur, so any unusual symptoms should be reported to a doctor immediately. During treatment, care should be taken when using other antihypertensive agents, potassium-sparing diuretics, or potassium supplements, as blood potassium levels may increase. Co-administration with lithium formulations may result in elevated lithium levels and toxicity, so they should not be taken together. Co-administration with non-steroidal anti-inflammatory drugs may worsen kidney function, so kidney function should be monitored regularly during treatment. Women who are pregnant or breastfeeding should avoid this medication, especially during pregnancy due to the serious risk to the fetus, requiring discontinuation of the medication. Safety for use in children has not been established, thus it is not used in pediatric patients. Elderly patients may experience increased drug concentrations and thus caution is advised during use. Overdose may lead to hypotension or arrhythmias, requiring appropriate treatment. This medication has been reported to have a low risk of carcinogenicity or genotoxicity even with long-term use, but any unusual symptoms during use should be discussed with a doctor.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. It is recommended to keep it at room temperature between 1 to 25 degrees Celsius. This helps maintain the medication's effectiveness for a longer period.
White oval film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowOlmesartan Medoxomil 40mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
Jongkeundang Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Jinyang Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Teragen Itex Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.